NewSquare Capital’s Accendra Health ACH Stock Holding History

NewSquare Capital’s Portfolio ACH Stock Details ACH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-17	Closed	-$324	–	805
2023 Q2	$324	Hold	17	–	–	﹤0.01%	728
2023 Q1	$247	Hold	17	–	–	﹤0.01%	776
2022 Q4	$332	Buy	+17	New	+$332	﹤0.01%	691

Other funds holding ACH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

NewSquare Capital's ACH Position: Q3 2023 in Review

NewSquare Capital sold out of Accendra Health (ACH) in Q3 2023, closing a stake of 17 shares — an estimated $324 sold.

NewSquare Capital first reported a position in ACH in Q4 2022 and held it in 3 quarters. The position peaked at $332 in Q4 2022. 211 funds tracked by Wall St. Rank hold ACH as of Q3 2023.

NewSquare Capital reported no remaining Accendra Health position as of Q3 2023 after selling out during the quarter.
NewSquare Capital sold 17 Accendra Health shares in Q3 2023, an estimated $324.
NewSquare Capital first reported a position in Accendra Health in Q4 2022 and held it in 3 quarters.
NewSquare Capital's Accendra Health position peaked at $332 in Q4 2022.
211 funds tracked by Wall St. Rank held Accendra Health as of Q3 2023.

Based on NewSquare Capital's 13F filing for Q3 2023, filed 3 Nov 2023.